Artal Group S.A.
- SEC CIK
- 0001053906
- Latest filing
- Aug 13, 2026
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 12, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 135
- −9 vs. Q4 2021
- Portfolio value
- $2.37B
- −$1.04B (−30.5%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ARGXArgenx SE | SPONSORED ADR | 587,500 | $185.2M | 7.8% | +87,500+17.5% | Added | History |
| WWWW International, Inc. | COM | 14,818,300 | $151.6M | 6.4% | 00.0% | Unchanged | History |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 71,178,364 | $148.8M | 6.3% | 00.0% | Unchanged | History |
| ONCBeOne Medicines Ltd. | ADR | 665,000 | $125.4M | 5.3% | −10,000−1.5% | Reduced | History |
| MRTXMirati Therapeutics, Inc. | COM | 1,350,000 | $111.0M | 4.7% | −50,000−3.6% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 650,000 | $106.1M | 4.5% | 00.0% | Unchanged | History |
| SGENSeagen Inc. | COM | 650,000 | $93.6M | 4.0% | +150,000+30.0% | Added | History |
| FATEFate Therapeutics Inc | COM | 2,000,000 | $77.5M | 3.3% | +200,000+11.1% | Added | History |
| SEERSeer, Inc. | COM CL A | 4,750,000 | $72.4M | 3.1% | 00.0% | Unchanged | History |
| MORFMorphic Holding, Inc. | COM | 1,650,000 | $66.2M | 2.8% | +64,951+4.1% | Added | History |
| Bellus Health Inc New07987C204 | COM NEW | 8,500,000 | $58.5M | 2.5% | 00.0% | Unchanged | – |
| IGMSIGM Biosciences, Inc. | COM | 2,000,000 | $53.5M | 2.3% | +500,000+33.3% | Added | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 1,500,000 | $52.5M | 2.2% | 00.0% | Unchanged | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 850,000 | $48.0M | 2.0% | 00.0% | Unchanged | History |
| KYMRKymera Therapeutics, Inc. | COM | 1,000,000 | $42.3M | 1.8% | 00.0% | Unchanged | History |
| FOLDAmicus Therapeutics, Inc. | COM | 4,000,000 | $37.9M | 1.6% | −2,000,000−33.3% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 1,000,000 | $36.8M | 1.6% | 00.0% | Unchanged | History |
| KRYSKrystal Biotech, Inc. | COM | 500,000 | $33.3M | 1.4% | −200,000−28.6% | Reduced | History |
| SRRKScholar Rock Holding Corp | COM | 2,450,000 | $31.6M | 1.3% | 00.0% | Unchanged | History |
| ERASErasca, Inc. | COM | 3,172,221 | $27.3M | 1.2% | 00.0% | Unchanged | History |
| FHTXFoghorn Therapeutics Inc. | COM | 1,720,720 | $26.2M | 1.1% | 00.0% | Unchanged | History |
| SAGESage Therapeutics, Inc. | COM | 750,000 | $24.8M | 1.0% | −250,000−25.0% | Reduced | History |
| SDGRSchrodinger, Inc. | COM | 700,000 | $23.9M | 1.0% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 700,000 | $21.0M | 0.9% | −50,000−6.7% | Reduced | History |
| GBIOGeneration Bio Co. | COM | 2,814,191 | $20.7M | 0.9% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 2,358,968 | $20.5M | 0.9% | 00.0% | Unchanged | History |
| RUBYRubius Therapeutics, Inc. | COM | 3,701,580 | $20.4M | 0.9% | 00.0% | Unchanged | History |
| TRMLTourmaline Bio, Inc. | COM | 2,064,262 | $20.3M | 0.9% | 00.0% | Unchanged | History |
| NTLAIntellia Therapeutics, Inc. | COM | 275,000 | $20.0M | 0.8% | 00.0% | Unchanged | History |
| DNLIDenali Therapeutics Inc. | COM | 600,000 | $19.3M | 0.8% | 00.0% | Unchanged | History |
| PTGXProtagonist Therapeutics, Inc | COM | 800,100 | $18.9M | 0.8% | −449,900−36.0% | Reduced | History |
| EVOEvotec SE | SPONSORED ADS | 1,149,425 | $17.4M | 0.7% | 00.0% | Unchanged | History |
| KURAKura Oncology, Inc. | COM | 1,050,000 | $16.9M | 0.7% | 00.0% | Unchanged | History |
| EQRXEQRx, Inc. | COM | 4,000,000 | $16.5M | 0.7% | 00.0% | Unchanged | History |
| KLRSKalaris Therapeutics, Inc. | COM | 2,323,371 | $15.7M | 0.7% | 00.0% | Unchanged | History |
| REPLReplimune Group, Inc. | COM | 900,000 | $15.3M | 0.6% | 00.0% | Unchanged | History |
| OMGAOmega Therapeutics, Inc. | COMMON STOCK | 2,273,530 | $14.2M | 0.6% | 00.0% | Unchanged | History |
| APTXAptinyx Inc. | COM | 6,116,493 | $13.9M | 0.6% | 00.0% | Unchanged | History |
| NBPNovaBridge Biosciences | SPONSORED ADS | 850,000 | $13.8M | 0.6% | 00.0% | Unchanged | History |
| AGENAgenus Inc | COM NEW | 5,500,000 | $13.5M | 0.6% | −1,000,000−15.4% | Reduced | History |
| ITOSiTeos Therapeutics, Inc. | COM | 400,000 | $12.9M | 0.5% | −144,047−26.5% | Reduced | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 1,000,000 | $12.4M | 0.5% | 00.0% | Unchanged | History |
| PRAXPraxis Precision Medicines, Inc. | COM | 1,200,000 | $12.3M | 0.5% | 00.0% | Unchanged | History |
| KRONKronos Bio, Inc. | COM | 1,542,954 | $11.2M | 0.5% | 00.0% | Unchanged | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 200,000 | $10.2M | 0.4% | +200,000 | New | History |
| RPTXRepare Therapeutics Inc. | COM | 700,000 | $9.97M | 0.4% | 00.0% | Unchanged | History |
| IMAImageneBio, Inc. | COM | 1,549,513 | $9.45M | 0.4% | 00.0% | Unchanged | History |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 1,000,000 | $9.35M | 0.4% | 00.0% | Unchanged | History |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 1,000,000 | $9.30M | 0.4% | 00.0% | Unchanged | History |
| ATRAAtara Biotherapeutics, Inc. | COM | 1,000,000 | $9.29M | 0.4% | −500,000−33.3% | Reduced | History |
| VERVVerve Therapeutics, Inc. | COM | 400,000 | $9.13M | 0.4% | 00.0% | Unchanged | History |
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 2,152,291 | $8.87M | 0.4% | 00.0% | Unchanged | History |
| MRSNMersana Therapeutics, Inc. | COM | 2,200,000 | $8.78M | 0.4% | +1,000,000+83.3% | Added | History |
| ALXOAlx Oncology Holdings Inc | COM | 500,000 | $8.45M | 0.4% | 00.0% | Unchanged | History |
| Exscientia PLC30223G102 | ADS | 550,000 | $7.92M | 0.3% | 00.0% | Unchanged | – |
| IMUXImmunic, Inc. | COM | 700,000 | $7.91M | 0.3% | 00.0% | Unchanged | History |
| VIGLVigil Neuroscience, Inc. | COM | 1,121,191 | $7.88M | 0.3% | +1,121,191 | New | History |
| OVIDOvid Therapeutics Inc. | COM | 2,500,000 | $7.85M | 0.3% | 00.0% | Unchanged | History |
| SQZSQZ Biotechnologies Co | COM | 1,606,309 | $7.73M | 0.3% | 00.0% | Unchanged | History |
| TGTXTG Therapeutics, Inc. | COM | 800,000 | $7.61M | 0.3% | 00.0% | Unchanged | History |
| OTLYOatly Group AB | SPONSORED ADS | 1,500,000 | $7.51M | 0.3% | 00.0% | Unchanged | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,000,000 | $7.44M | 0.3% | 00.0% | Unchanged | History |
| Omega Alpha SpacG6749V107 | CL A | 750,000 | $7.37M | 0.3% | 00.0% | Unchanged | – |
| CYPHCypherpunk Technologies Inc. | COM | 4,000,000 | $7.00M | 0.3% | 00.0% | Unchanged | History |
| SESea Ltd | SPONSORD ADS | 57,500 | $6.89M | 0.3% | +57,500 | New | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,040,882 | $6.79M | 0.3% | 00.0% | Unchanged | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 2,255,375 | $6.63M | 0.3% | 00.0% | Unchanged | – |
| DSGNDesign Therapeutics, Inc. | COM | 400,000 | $6.46M | 0.3% | 00.0% | Unchanged | History |
| IMCRImmunocore Holdings plc | ADS | 200,000 | $5.98M | 0.3% | 00.0% | Unchanged | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 750,000 | $5.83M | 0.2% | 00.0% | Unchanged | History |
| CFRXCONTRAFECT Corp | COM NEW | 1,500,000 | $5.47M | 0.2% | 00.0% | Unchanged | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 593,030 | $5.32M | 0.2% | 00.0% | Unchanged | History |
| STOKStoke Therapeutics, Inc. | COM | 250,000 | $5.26M | 0.2% | 00.0% | Unchanged | History |
| DYNDyne Therapeutics, Inc. | COM | 525,000 | $5.06M | 0.2% | 00.0% | Unchanged | History |
| NEXINexImmune, Inc. | COM | 1,200,000 | $5.05M | 0.2% | 00.0% | Unchanged | History |
| HARPHarpoon Therapeutics, Inc. | COM | 1,000,000 | $4.97M | 0.2% | 00.0% | Unchanged | History |
| Dynamics Special Purpose Cor268010105 | CLASS A COM | 500,000 | $4.93M | 0.2% | 00.0% | Unchanged | – |
| RNACCartesian Therapeutics, Inc. | COM | 4,000,000 | $4.92M | 0.2% | 00.0% | Unchanged | History |
| TILInstil Bio, Inc. | COM | 450,000 | $4.84M | 0.2% | 00.0% | Unchanged | History |
| YMABY-mAbs Therapeutics, Inc. | COM | 400,000 | $4.75M | 0.2% | 00.0% | Unchanged | History |
| Avidity Biosciences, Inc.05370A108 | COM | 250,000 | $4.62M | 0.2% | 00.0% | Unchanged | – |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 1,646,517 | $4.56M | 0.2% | 00.0% | Unchanged | History |
| IVVDInvivyd, Inc. | COM | 1,000,000 | $4.56M | 0.2% | +1,000,000 | New | History |
| SPROSpero Therapeutics, Inc. | COM | 500,000 | $4.35M | 0.2% | 00.0% | Unchanged | History |
| HOOKHOOKIPA Pharma Inc. | COM | 1,849,616 | $4.22M | 0.2% | +1,250,000+208.5% | Added | History |
| SYRSSyros Pharmaceuticals, Inc. | COM | 3,500,000 | $4.17M | 0.2% | +500,000+16.7% | Added | History |
| MIRMirion Technologies, Inc. | COM CL A | 500,000 | $4.04M | 0.2% | 00.0% | Unchanged | History |
| ACIUAC Immune SA | SHS | 1,000,000 | $4.00M | 0.2% | 00.0% | Unchanged | History |
| ADVMAdverum Biotechnologies, Inc. | COM | 3,000,000 | $3.93M | 0.2% | 00.0% | Unchanged | History |
| PFTAPerception Capital Corp. III | CLASS A ORD SHS | 380,000 | $3.77M | 0.2% | 00.0% | Unchanged | History |
| SLDBSolid Biosciences Inc. | COM | 3,000,000 | $3.60M | 0.2% | 00.0% | Unchanged | History |
| LENZLENZ Therapeutics, Inc. | COM | 700,000 | $3.57M | 0.2% | 00.0% | Unchanged | History |
| LYELLyell Immunopharma, Inc. | COM | 700,000 | $3.54M | 0.1% | 00.0% | Unchanged | History |
| ADAGAdagene Inc. | ADS | 1,000,000 | $3.50M | 0.1% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM | 550,000 | $3.32M | 0.1% | 00.0% | Unchanged | History |
| SANASana Biotechnology, Inc. | COM | 400,000 | $3.30M | 0.1% | 00.0% | Unchanged | History |
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 450,000 | $3.22M | 0.1% | +250,000+125.0% | Added | History |
| XLOXilio Therapeutics, Inc. | COM | 450,000 | $3.18M | 0.1% | 00.0% | Unchanged | History |
| CRISCuris Inc | COM NEW | 1,300,000 | $3.09M | 0.1% | 00.0% | Unchanged | History |
| GRTSGritstone bio, Inc. | COM | 750,000 | $3.09M | 0.1% | 00.0% | Unchanged | History |
Options (2)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q4 2021 (16)
Positions held at the end of Q4 2021 that are gone from this filing.
| Security | Class | Shares in Q4 2021 | Value in Q4 2021 | % of portfolio in Q4 2021 | History |
|---|---|---|---|---|---|
| NGNovagold Resources Inc | COM NEW | 2,600,000 | $17.8M | 0.5% | History |
| ALBOAlbireo Pharma, Inc. | COM | 600,000 | $14.0M | 0.4% | History |
| TPTXTurning Point Therapeutics, Inc. | COM | 250,000 | $11.9M | 0.4% | History |
| EVLOEvelo Biosciences, Inc. | COM | 1,000,000 | $6.07M | 0.2% | History |
| SYRESpyre Therapeutics, Inc. | COM | 1,045,000 | $4.96M | 0.1% | History |
| GDSGDS Holdings Ltd | SPONSORED ADS | 100,000 | $4.72M | 0.1% | History |
| IQiQIYI, Inc. | SPONSORED ADS | 1,000,000 | $4.56M | 0.1% | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 200,000 | $3.93M | 0.1% | History |
| KDNYChinook Therapeutics, Inc. | COM | 180,500 | $2.94M | 0.1% | History |
| Amryt Pharma PLC03217L106 | SPONSORED ADS | 150,480 | $1.63M | <0.1% | – |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 100,000 | $977.0K | <0.1% | History |
| RIGLRigel Pharmaceuticals Inc | COM NEW | 321,100 | $851.0K | <0.1% | History |
| MBIIPro Farm Group, Inc. | COM | 1,048,679 | $755.0K | <0.1% | History |
| RIVNRivian Automotive, Inc. | Stock | 7,000 | $726.0K | <0.1% | History |
| DLOdLocal Ltd | CLASS A COM | 20,000 | $714.0K | <0.1% | History |
| SURFSurface Oncology, Inc. | COM | 100,000 | $478.0K | <0.1% | History |